Lazaroid U-74389G for cardioplegia-related ischemia-reperfusion injury: an experimental study

The present study, in addition to reconfirming the well-described adverse effects of CPB, demonstrates the efficacy of the newer generation lazaroid U-74389G in alleviating these effects.